[Etiologic and therapeutic significance of endorphins in endogenous psychoses].
D003866:Depressive Disorder / Q000188:drug therapy; D004311:Double-Blind Method; D004723:Endorphins / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D009270:Naloxone / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011957:Receptors, Opioid / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy; D001615:beta-Endorphin
D004723:Endorphins; D011619:Psychotropic Drugs; D011957:Receptors, Opioid; D009270:Naloxone; D001615:beta-Endorphin; D011388:Prolactin; D006854:Hydrocortisone
Zur ätiologischen und therapeutischen Bedeutung von Endorphinen bei endogenen Psychosen.